These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 15725032)

  • 1. Development of a technique to determine bicyclomycin-rho binding and stoichiometry by isothermal titration calorimetry and mass spectrometry.
    Brogan AP; Widger WR; Bensadek D; Riba-Garcia I; Gaskell SJ; Kohn H
    J Am Chem Soc; 2005 Mar; 127(8):2741-51. PubMed ID: 15725032
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Structural mechanism of inhibition of the Rho transcription termination factor by the antibiotic bicyclomycin.
    Skordalakes E; Brogan AP; Park BS; Kohn H; Berger JM
    Structure; 2005 Jan; 13(1):99-109. PubMed ID: 15642265
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 5a-formylbicyclomycin: studies on the bicyclomycin-Rho interaction.
    Vincent F; Widger WR; Openshaw M; Gaskell SJ; Kohn H
    Biochemistry; 2000 Aug; 39(31):9067-76. PubMed ID: 10924099
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evidence for the location of bicyclomycin binding to the Escherichia coli transcription termination factor Rho.
    Riba I; Gaskell SJ; Cho H; Widger WR; Kohn H
    J Biol Chem; 1998 Dec; 273(51):34033-41. PubMed ID: 9852059
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Rho transcription factor: symmetry and binding of bicyclomycin.
    Vincent F; Openshaw M; Trautwein M; Gaskell SJ; Kohn H; Widger WR
    Biochemistry; 2000 Aug; 39(31):9077-83. PubMed ID: 10924100
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The molecular basis for the mode of action of bicyclomycin.
    Kohn H; Widger W
    Curr Drug Targets Infect Disord; 2005 Sep; 5(3):273-95. PubMed ID: 16181146
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bicyclomycin and dihydrobicyclomycin inhibition kinetics of Escherichia coli rho-dependent transcription termination factor ATPase activity.
    Park HG; Zhang X; Moon HS; Zwiefka A; Cox K; Gaskell SJ; Widger WR; Kohn H
    Arch Biochem Biophys; 1995 Nov; 323(2):447-54. PubMed ID: 7487110
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The antibiotic bicyclomycin affects the secondary RNA binding site of Escherichia coli transcription termination factor Rho.
    Magyar A; Zhang X; Kohn H; Widger WR
    J Biol Chem; 1996 Oct; 271(41):25369-74. PubMed ID: 8810302
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The bicyclomycin sensitivities of 38 bicyclomycin-resistant mutants of transcription termination protein rho and the location of their mutations support a structural model of rho based on the F(1) ATPase.
    Moyse KA; Knight JS; Richardson JP
    J Mol Biol; 2000 Sep; 302(3):565-79. PubMed ID: 10986119
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bicyclomycin fluorescent probes: synthesis and biochemical, biophysical, and biological properties.
    Brogan AP; Widger WR; Kohn H
    J Org Chem; 2003 Jul; 68(14):5575-87. PubMed ID: 12839449
    [TBL] [Abstract][Full Text] [Related]  

  • 11. ATP binding to Rho transcription termination factor. Mutant F355W ATP-induced fluorescence quenching reveals dynamic ATP binding.
    Xu Y; Johnson J; Kohn H; Widger WR
    J Biol Chem; 2003 Apr; 278(16):13719-27. PubMed ID: 12551938
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Mg2+ requirements for rho transcription termination factor: catalysis and bicyclomycin inhibition.
    Weber TP; Widger WR; Kohn H
    Biochemistry; 2002 Oct; 41(41):12377-83. PubMed ID: 12369827
    [TBL] [Abstract][Full Text] [Related]  

  • 13. C(5)-C(5a)-modified bicyclomycins: synthesis, structure, and biochemical and biological properties.
    Vincent F; Srinivasan J; Santillán A; Widger WR; Kohn H
    J Org Chem; 2001 Apr; 66(7):2251-64. PubMed ID: 11281764
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Transcription termination factor rho: the site of bicyclomycin inhibition in Escherichia coli.
    Zwiefka A; Kohn H; Widger WR
    Biochemistry; 1993 Apr; 32(14):3564-70. PubMed ID: 8466900
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of bicyclomycin on RNA- and ATP-binding activities of transcription termination factor Rho.
    Carrano L; Bucci C; De Pascalis R; Lavitola A; Manna F; Corti E; Bruni CB; Alifano P
    Antimicrob Agents Chemother; 1998 Mar; 42(3):571-8. PubMed ID: 9517934
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Functional interactions of ligand cofactors with Escherichia coli transcription termination factor rho. I. Binding of ATP.
    Geiselmann J; von Hippel PH
    Protein Sci; 1992 Jul; 1(7):850-60. PubMed ID: 1304371
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identifying the bicyclomycin binding domain through biochemical analysis of antibiotic-resistant rho proteins.
    Magyar A; Zhang X; Abdi F; Kohn H; Widger WR
    J Biol Chem; 1999 Mar; 274(11):7316-24. PubMed ID: 10066795
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A new inhibitor of the transcription-termination factor Rho.
    Carrano L; Alifano P; Corti E; Bucci C; Donadio S
    Biochem Biophys Res Commun; 2003 Mar; 302(2):219-25. PubMed ID: 12604334
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ligand-induced and small-molecule control of substrate loading in a hexameric helicase.
    Lawson MR; Dyer K; Berger JM
    Proc Natl Acad Sci U S A; 2016 Nov; 113(48):13714-13719. PubMed ID: 27821776
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mechanochemistry of transcription termination factor Rho.
    Adelman JL; Jeong YJ; Liao JC; Patel G; Kim DE; Oster G; Patel SS
    Mol Cell; 2006 Jun; 22(5):611-21. PubMed ID: 16762834
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.